Drug Manufacturers
CVS raises profit forecast, in talks with US to administer Covid vaccines
Govt notifies incentive scheme for local API manufacturing to cut imports
Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial
Pvt players must help set up bulk drug, med devices pak: Mandaviya
Glenmark Pharma gets nod to launch favipiravir for Covid-19 patients

Lupin recieves USFDA nod to market generic anthelmintic tablets
Revised Wockhardt deal boosts prospects of Dr Reddy's India business
Joint inflammation drug may be repurposed to treat Covid-19: EMBO Study
Chennai-based start-up developing Covid-19 remedy, plans to test in US
AstraZeneca, Gilead merger likely to hit political, strategic hurdles

Remdesivir pricing in India likely to be lower than global rate: Sources
Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business
Antiviral drugs see demand surge in India, but segment declines 5.5%
Coronavirus: UP govt reopens 5,200 industrial units during lockdown
Coronavirus outbreak: Pharma market grows 9% in March due to panic buying
Coronavirus: ITC repurposes Himachal perfume plant to produce sanitisers
Govt allows doorstep delivery of drugs to help citizens under lockdown
Govt approves Rs 13K-crore package to boost bulk drugs manufacture
Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems
Demand for chronic illness medicines rising faster than acute drugs: Report